Supported by george james ltd, specialists in Recruitment, Training and Corporate Development in the Life Science industry, www.georgejamesltd.co.uk

January 2017
Latest News in Personalized and Precision Medicine

FDA holding off on finalizing regulatory guidance for lab-developed tests read on...
Nivolumab shows promise in mesothelioma read on...
Passage of the 21st Century Cures Act by Congress will produce sweeping changes to the biotech, medical device, pharmaceutical, and health industries read on...
CMS reimbursement update read on...
Trovagene is out of the CLIA lab business read on...
New immunotherapy clinic read on...
Colorectal cancers on the rise in younger adults read on...
More activity outside oncology - UCB and epilepsy Dx read on...
How should patients be monitored for prostate cancer after a negative biopsy? read on...
The numbers behind a pharma CEO shouting match read on...
The AR-V7 story is more complex read on...
New lung biomarker website sponsored by Merck read on...
QuantuMDx wins Gates Foundation funds for point-of-care TB MDx read on...
Despite Lilly flop, Wall Street wags remain bullish on Biogen Alzheimer's drug read on...
EU approves Opdivo for classical Hodgkin's lymphoma read on...
Lilly's Alzheimer's drug fails in final-stage trial read on...
NHS cancer testing service 'at breaking point' read on...
This month in Diaceutics news

[Webinar] Which Pharma Companies Are Ready For Precision Medicine in 2017? Benchmarking, Financial Risks and Predictions. read on...
[Media Mention] Pharma Readiness for Dx Index read on...


     

© 2016 Diaceutics Group. All rights reserved.